nodes	percent_of_prediction	percent_of_DWPC	metapath
Cyproterone acetate—AR—obesity	0.28	0.398	CbGaD
Cyproterone acetate—CYP19A1—obesity	0.234	0.333	CbGaD
Cyproterone acetate—NR3C1—obesity	0.19	0.27	CbGaD
Cyproterone acetate—CYP19A1—ovarian follicle—obesity	0.0111	0.376	CbGeAlD
Cyproterone acetate—NR3C1—hindbrain—obesity	0.00154	0.0521	CbGeAlD
Cyproterone acetate—AR—adrenal cortex—obesity	0.00109	0.0369	CbGeAlD
Cyproterone acetate—Medroxyprogesterone Acetate—AKR1C3—obesity	0.00104	0.251	CrCbGaD
Cyproterone acetate—NR3C1—islet of Langerhans—obesity	0.000994	0.0337	CbGeAlD
Cyproterone acetate—AR—cardiovascular system—obesity	0.000992	0.0336	CbGeAlD
Cyproterone acetate—CYP19A1—adipose tissue—obesity	0.000988	0.0335	CbGeAlD
Cyproterone acetate—NR3C1—respiratory system—obesity	0.000938	0.0318	CbGeAlD
Cyproterone acetate—CYP19A1—adrenal gland—obesity	0.000887	0.03	CbGeAlD
Cyproterone acetate—AR—pituitary gland—obesity	0.000879	0.0298	CbGeAlD
Cyproterone acetate—AR—adipose tissue—obesity	0.000875	0.0297	CbGeAlD
Cyproterone acetate—Ethynodiol—ESR1—obesity	0.000856	0.207	CrCbGaD
Cyproterone acetate—AR—digestive system—obesity	0.000824	0.0279	CbGeAlD
Cyproterone acetate—NR3C1—adrenal cortex—obesity	0.000788	0.0267	CbGeAlD
Cyproterone acetate—AR—adrenal gland—obesity	0.000785	0.0266	CbGeAlD
Cyproterone acetate—CYP19A1—endocrine gland—obesity	0.000769	0.0261	CbGeAlD
Cyproterone acetate—NR3C1—cardiovascular system—obesity	0.000719	0.0244	CbGeAlD
Cyproterone acetate—CYP19A1—liver—obesity	0.000693	0.0235	CbGeAlD
Cyproterone acetate—AR—endocrine gland—obesity	0.000681	0.0231	CbGeAlD
Cyproterone acetate—NR3C1—pituitary gland—obesity	0.000636	0.0216	CbGeAlD
Cyproterone acetate—NR3C1—adipose tissue—obesity	0.000634	0.0215	CbGeAlD
Cyproterone acetate—AR—liver—obesity	0.000614	0.0208	CbGeAlD
Cyproterone acetate—NR3C1—digestive system—obesity	0.000597	0.0202	CbGeAlD
Cyproterone acetate—NR3C1—adrenal gland—obesity	0.000568	0.0193	CbGeAlD
Cyproterone acetate—Megestrol acetate—NR3C1—obesity	0.000551	0.133	CrCbGaD
Cyproterone acetate—Medroxyprogesterone Acetate—SHBG—obesity	0.00054	0.13	CrCbGaD
Cyproterone acetate—NR3C1—endocrine gland—obesity	0.000493	0.0167	CbGeAlD
Cyproterone acetate—Medroxyprogesterone Acetate—AR—obesity	0.000473	0.114	CrCbGaD
Cyproterone acetate—NR3C1—liver—obesity	0.000444	0.0151	CbGeAlD
Cyproterone acetate—Medroxyprogesterone Acetate—ESR1—obesity	0.000365	0.088	CrCbGaD
Cyproterone acetate—Medroxyprogesterone Acetate—NR3C1—obesity	0.000321	0.0774	CrCbGaD
Cyproterone acetate—Pollakiuria—Bupropion—obesity	0.000275	0.00155	CcSEcCtD
Cyproterone acetate—Rash maculo-papular—Topiramate—obesity	0.000275	0.00155	CcSEcCtD
Cyproterone acetate—Haemoglobin—Sibutramine—obesity	0.000275	0.00155	CcSEcCtD
Cyproterone acetate—Erectile dysfunction—Bupropion—obesity	0.000274	0.00154	CcSEcCtD
Cyproterone acetate—Haemorrhage—Sibutramine—obesity	0.000273	0.00154	CcSEcCtD
Cyproterone acetate—Neoplasm—Topiramate—obesity	0.000273	0.00154	CcSEcCtD
Cyproterone acetate—Nausea—Phenylpropanolamine—obesity	0.000272	0.00153	CcSEcCtD
Cyproterone acetate—Photosensitivity reaction—Bupropion—obesity	0.000272	0.00153	CcSEcCtD
Cyproterone acetate—Weight increased—Bupropion—obesity	0.000271	0.00152	CcSEcCtD
Cyproterone acetate—Weight decreased—Bupropion—obesity	0.000269	0.00152	CcSEcCtD
Cyproterone acetate—Hyperglycaemia—Bupropion—obesity	0.000268	0.00151	CcSEcCtD
Cyproterone acetate—Hypersensitivity—Cimetidine—obesity	0.000268	0.00151	CcSEcCtD
Cyproterone acetate—Abnormal vision—Topiramate—obesity	0.000264	0.00148	CcSEcCtD
Cyproterone acetate—Visual impairment—Sibutramine—obesity	0.000263	0.00148	CcSEcCtD
Cyproterone acetate—Acute coronary syndrome—Bupropion—obesity	0.000262	0.00147	CcSEcCtD
Cyproterone acetate—Diarrhoea—Diethylpropion—obesity	0.000261	0.00147	CcSEcCtD
Cyproterone acetate—Nausea—Phentermine—obesity	0.000261	0.00147	CcSEcCtD
Cyproterone acetate—Asthenia—Cimetidine—obesity	0.000261	0.00147	CcSEcCtD
Cyproterone acetate—Myocardial infarction—Bupropion—obesity	0.00026	0.00146	CcSEcCtD
Cyproterone acetate—Jaundice—Bupropion—obesity	0.000259	0.00146	CcSEcCtD
Cyproterone acetate—Eye disorder—Sibutramine—obesity	0.000255	0.00144	CcSEcCtD
Cyproterone acetate—Immune system disorder—Orlistat—obesity	0.000255	0.00144	CcSEcCtD
Cyproterone acetate—Phlebitis—Topiramate—obesity	0.000255	0.00143	CcSEcCtD
Cyproterone acetate—Mediastinal disorder—Orlistat—obesity	0.000254	0.00143	CcSEcCtD
Cyproterone acetate—Sweating—Bupropion—obesity	0.000254	0.00143	CcSEcCtD
Cyproterone acetate—Sleep disorder—Topiramate—obesity	0.000253	0.00143	CcSEcCtD
Cyproterone acetate—Dizziness—Diethylpropion—obesity	0.000253	0.00142	CcSEcCtD
Cyproterone acetate—Diabetes mellitus—Topiramate—obesity	0.000252	0.00142	CcSEcCtD
Cyproterone acetate—Alopecia—Orlistat—obesity	0.000249	0.0014	CcSEcCtD
Cyproterone acetate—Diarrhoea—Cimetidine—obesity	0.000249	0.0014	CcSEcCtD
Cyproterone acetate—Angiopathy—Sibutramine—obesity	0.000248	0.0014	CcSEcCtD
Cyproterone acetate—Mental disorder—Orlistat—obesity	0.000247	0.00139	CcSEcCtD
Cyproterone acetate—Immune system disorder—Sibutramine—obesity	0.000247	0.00139	CcSEcCtD
Cyproterone acetate—Malnutrition—Orlistat—obesity	0.000246	0.00138	CcSEcCtD
Cyproterone acetate—Chills—Sibutramine—obesity	0.000245	0.00138	CcSEcCtD
Cyproterone acetate—Eczema—Topiramate—obesity	0.000244	0.00137	CcSEcCtD
Cyproterone acetate—Hepatic failure—Topiramate—obesity	0.000244	0.00137	CcSEcCtD
Cyproterone acetate—Vomiting—Diethylpropion—obesity	0.000243	0.00137	CcSEcCtD
Cyproterone acetate—Alopecia—Sibutramine—obesity	0.000241	0.00136	CcSEcCtD
Cyproterone acetate—Rash—Diethylpropion—obesity	0.000241	0.00136	CcSEcCtD
Cyproterone acetate—Dermatitis—Diethylpropion—obesity	0.000241	0.00135	CcSEcCtD
Cyproterone acetate—Dizziness—Cimetidine—obesity	0.00024	0.00135	CcSEcCtD
Cyproterone acetate—Haemoglobin—Bupropion—obesity	0.000239	0.00135	CcSEcCtD
Cyproterone acetate—Headache—Diethylpropion—obesity	0.000239	0.00135	CcSEcCtD
Cyproterone acetate—Haemorrhage—Bupropion—obesity	0.000238	0.00134	CcSEcCtD
Cyproterone acetate—Hepatitis—Bupropion—obesity	0.000238	0.00134	CcSEcCtD
Cyproterone acetate—Malnutrition—Sibutramine—obesity	0.000238	0.00134	CcSEcCtD
Cyproterone acetate—Libido decreased—Topiramate—obesity	0.000237	0.00133	CcSEcCtD
Cyproterone acetate—Hot flush—Topiramate—obesity	0.000235	0.00132	CcSEcCtD
Cyproterone acetate—Connective tissue disorder—Bupropion—obesity	0.000234	0.00132	CcSEcCtD
Cyproterone acetate—Tension—Sibutramine—obesity	0.000233	0.00131	CcSEcCtD
Cyproterone acetate—Menopausal symptoms—Topiramate—obesity	0.000232	0.00131	CcSEcCtD
Cyproterone acetate—Vomiting—Cimetidine—obesity	0.000231	0.0013	CcSEcCtD
Cyproterone acetate—Visual impairment—Bupropion—obesity	0.00023	0.00129	CcSEcCtD
Cyproterone acetate—Rash—Cimetidine—obesity	0.000229	0.00129	CcSEcCtD
Cyproterone acetate—Dermatitis—Cimetidine—obesity	0.000229	0.00129	CcSEcCtD
Cyproterone acetate—Ill-defined disorder—Orlistat—obesity	0.000228	0.00128	CcSEcCtD
Cyproterone acetate—Headache—Cimetidine—obesity	0.000228	0.00128	CcSEcCtD
Cyproterone acetate—Nausea—Diethylpropion—obesity	0.000227	0.00128	CcSEcCtD
Cyproterone acetate—Erythema multiforme—Bupropion—obesity	0.000225	0.00127	CcSEcCtD
Cyproterone acetate—Eye disorder—Bupropion—obesity	0.000223	0.00125	CcSEcCtD
Cyproterone acetate—Malaise—Orlistat—obesity	0.000222	0.00125	CcSEcCtD
Cyproterone acetate—Ill-defined disorder—Sibutramine—obesity	0.000221	0.00124	CcSEcCtD
Cyproterone acetate—Anaemia—Sibutramine—obesity	0.00022	0.00124	CcSEcCtD
Cyproterone acetate—Agitation—Sibutramine—obesity	0.000219	0.00123	CcSEcCtD
Cyproterone acetate—Disturbance in sexual arousal—Topiramate—obesity	0.000218	0.00123	CcSEcCtD
Cyproterone acetate—Angiopathy—Bupropion—obesity	0.000216	0.00122	CcSEcCtD
Cyproterone acetate—Affect lability—Topiramate—obesity	0.000216	0.00122	CcSEcCtD
Cyproterone acetate—Migraine—Topiramate—obesity	0.000216	0.00122	CcSEcCtD
Cyproterone acetate—Nausea—Cimetidine—obesity	0.000216	0.00121	CcSEcCtD
Cyproterone acetate—Immune system disorder—Bupropion—obesity	0.000215	0.00121	CcSEcCtD
Cyproterone acetate—Mediastinal disorder—Bupropion—obesity	0.000215	0.00121	CcSEcCtD
Cyproterone acetate—Malaise—Sibutramine—obesity	0.000215	0.00121	CcSEcCtD
Cyproterone acetate—Cough—Orlistat—obesity	0.000214	0.00121	CcSEcCtD
Cyproterone acetate—Chills—Bupropion—obesity	0.000214	0.0012	CcSEcCtD
Cyproterone acetate—Syncope—Sibutramine—obesity	0.000213	0.0012	CcSEcCtD
Cyproterone acetate—Leukopenia—Sibutramine—obesity	0.000213	0.0012	CcSEcCtD
Cyproterone acetate—Alopecia—Bupropion—obesity	0.000211	0.00118	CcSEcCtD
Cyproterone acetate—Loss of consciousness—Sibutramine—obesity	0.000209	0.00118	CcSEcCtD
Cyproterone acetate—Mental disorder—Bupropion—obesity	0.000209	0.00117	CcSEcCtD
Cyproterone acetate—Mood swings—Topiramate—obesity	0.000208	0.00117	CcSEcCtD
Cyproterone acetate—Unspecified disorder of skin and subcutaneous tissue—Orlistat—obesity	0.000208	0.00117	CcSEcCtD
Cyproterone acetate—Cough—Sibutramine—obesity	0.000208	0.00117	CcSEcCtD
Cyproterone acetate—Malnutrition—Bupropion—obesity	0.000207	0.00117	CcSEcCtD
Cyproterone acetate—Discomfort—Orlistat—obesity	0.000207	0.00116	CcSEcCtD
Cyproterone acetate—Blood creatinine increased—Topiramate—obesity	0.000206	0.00116	CcSEcCtD
Cyproterone acetate—Tension—Bupropion—obesity	0.000203	0.00115	CcSEcCtD
Cyproterone acetate—Liver function test abnormal—Topiramate—obesity	0.000203	0.00114	CcSEcCtD
Cyproterone acetate—Oedema—Orlistat—obesity	0.000201	0.00113	CcSEcCtD
Cyproterone acetate—Discomfort—Sibutramine—obesity	0.0002	0.00113	CcSEcCtD
Cyproterone acetate—Breast disorder—Topiramate—obesity	0.000198	0.00112	CcSEcCtD
Cyproterone acetate—Aspartate aminotransferase increased—Topiramate—obesity	0.000198	0.00111	CcSEcCtD
Cyproterone acetate—Nervous system disorder—Orlistat—obesity	0.000197	0.00111	CcSEcCtD
Cyproterone acetate—Skin disorder—Orlistat—obesity	0.000195	0.0011	CcSEcCtD
Cyproterone acetate—Oedema—Sibutramine—obesity	0.000194	0.00109	CcSEcCtD
Cyproterone acetate—Hyperhidrosis—Orlistat—obesity	0.000194	0.00109	CcSEcCtD
Cyproterone acetate—Alanine aminotransferase increased—Topiramate—obesity	0.000193	0.00109	CcSEcCtD
Cyproterone acetate—Muscular weakness—Topiramate—obesity	0.000193	0.00109	CcSEcCtD
Cyproterone acetate—Ill-defined disorder—Bupropion—obesity	0.000192	0.00108	CcSEcCtD
Cyproterone acetate—Anaemia—Bupropion—obesity	0.000192	0.00108	CcSEcCtD
Cyproterone acetate—Shock—Sibutramine—obesity	0.000191	0.00108	CcSEcCtD
Cyproterone acetate—Agitation—Bupropion—obesity	0.000191	0.00107	CcSEcCtD
Cyproterone acetate—Thrombocytopenia—Sibutramine—obesity	0.00019	0.00107	CcSEcCtD
Cyproterone acetate—Asthma—Topiramate—obesity	0.00019	0.00107	CcSEcCtD
Cyproterone acetate—Tachycardia—Sibutramine—obesity	0.000189	0.00107	CcSEcCtD
Cyproterone acetate—Skin disorder—Sibutramine—obesity	0.000189	0.00106	CcSEcCtD
Cyproterone acetate—Hyperhidrosis—Sibutramine—obesity	0.000188	0.00106	CcSEcCtD
Cyproterone acetate—Malaise—Bupropion—obesity	0.000187	0.00105	CcSEcCtD
Cyproterone acetate—Syncope—Bupropion—obesity	0.000186	0.00105	CcSEcCtD
Cyproterone acetate—Pancreatitis—Topiramate—obesity	0.000186	0.00105	CcSEcCtD
Cyproterone acetate—Leukopenia—Bupropion—obesity	0.000186	0.00104	CcSEcCtD
Cyproterone acetate—Anorexia—Sibutramine—obesity	0.000185	0.00104	CcSEcCtD
Cyproterone acetate—Sweating increased—Topiramate—obesity	0.000185	0.00104	CcSEcCtD
Cyproterone acetate—Loss of consciousness—Bupropion—obesity	0.000182	0.00103	CcSEcCtD
Cyproterone acetate—Hypotension—Sibutramine—obesity	0.000181	0.00102	CcSEcCtD
Cyproterone acetate—Cough—Bupropion—obesity	0.000181	0.00102	CcSEcCtD
Cyproterone acetate—Dyspepsia—Orlistat—obesity	0.000177	0.000994	CcSEcCtD
Cyproterone acetate—Unspecified disorder of skin and subcutaneous tissue—Bupropion—obesity	0.000175	0.000987	CcSEcCtD
Cyproterone acetate—Pollakiuria—Topiramate—obesity	0.000175	0.000986	CcSEcCtD
Cyproterone acetate—Erectile dysfunction—Topiramate—obesity	0.000175	0.000983	CcSEcCtD
Cyproterone acetate—Discomfort—Bupropion—obesity	0.000174	0.000982	CcSEcCtD
Cyproterone acetate—Decreased appetite—Orlistat—obesity	0.000174	0.000982	CcSEcCtD
Cyproterone acetate—Gastrointestinal disorder—Orlistat—obesity	0.000173	0.000975	CcSEcCtD
Cyproterone acetate—Dyspnoea—Sibutramine—obesity	0.000173	0.000974	CcSEcCtD
Cyproterone acetate—Photosensitivity reaction—Topiramate—obesity	0.000173	0.000974	CcSEcCtD
Cyproterone acetate—Fatigue—Orlistat—obesity	0.000173	0.000974	CcSEcCtD
Cyproterone acetate—Weight increased—Topiramate—obesity	0.000173	0.000971	CcSEcCtD
Cyproterone acetate—Weight decreased—Topiramate—obesity	0.000172	0.000966	CcSEcCtD
Cyproterone acetate—Hyperglycaemia—Topiramate—obesity	0.000171	0.000963	CcSEcCtD
Cyproterone acetate—Dyspepsia—Sibutramine—obesity	0.000171	0.000962	CcSEcCtD
Cyproterone acetate—Oedema—Bupropion—obesity	0.000169	0.000953	CcSEcCtD
Cyproterone acetate—Decreased appetite—Sibutramine—obesity	0.000169	0.00095	CcSEcCtD
Cyproterone acetate—Gastrointestinal disorder—Sibutramine—obesity	0.000168	0.000943	CcSEcCtD
Cyproterone acetate—Shock—Bupropion—obesity	0.000167	0.000937	CcSEcCtD
Cyproterone acetate—Renal failure—Topiramate—obesity	0.000166	0.000936	CcSEcCtD
Cyproterone acetate—Constipation—Sibutramine—obesity	0.000166	0.000935	CcSEcCtD
Cyproterone acetate—Nervous system disorder—Bupropion—obesity	0.000166	0.000934	CcSEcCtD
Cyproterone acetate—Thrombocytopenia—Bupropion—obesity	0.000166	0.000933	CcSEcCtD
Cyproterone acetate—Feeling abnormal—Orlistat—obesity	0.000165	0.000931	CcSEcCtD
Cyproterone acetate—Tachycardia—Bupropion—obesity	0.000165	0.00093	CcSEcCtD
Cyproterone acetate—Skin disorder—Bupropion—obesity	0.000164	0.000925	CcSEcCtD
Cyproterone acetate—Gastrointestinal pain—Orlistat—obesity	0.000164	0.000923	CcSEcCtD
Cyproterone acetate—Hyperhidrosis—Bupropion—obesity	0.000164	0.000921	CcSEcCtD
Cyproterone acetate—Anorexia—Bupropion—obesity	0.000161	0.000908	CcSEcCtD
Cyproterone acetate—Haematuria—Topiramate—obesity	0.000161	0.000907	CcSEcCtD
Cyproterone acetate—Feeling abnormal—Sibutramine—obesity	0.00016	0.000901	CcSEcCtD
Cyproterone acetate—Urticaria—Orlistat—obesity	0.000159	0.000897	CcSEcCtD
Cyproterone acetate—Gastrointestinal pain—Sibutramine—obesity	0.000159	0.000894	CcSEcCtD
Cyproterone acetate—Abdominal pain—Orlistat—obesity	0.000159	0.000893	CcSEcCtD
Cyproterone acetate—Body temperature increased—Orlistat—obesity	0.000159	0.000893	CcSEcCtD
Cyproterone acetate—Hypotension—Bupropion—obesity	0.000158	0.00089	CcSEcCtD
Cyproterone acetate—Urticaria—Sibutramine—obesity	0.000154	0.000868	CcSEcCtD
Cyproterone acetate—Abdominal pain—Sibutramine—obesity	0.000153	0.000864	CcSEcCtD
Cyproterone acetate—Body temperature increased—Sibutramine—obesity	0.000153	0.000864	CcSEcCtD
Cyproterone acetate—Haemoglobin—Topiramate—obesity	0.000153	0.000859	CcSEcCtD
Cyproterone acetate—Haemorrhage—Topiramate—obesity	0.000152	0.000854	CcSEcCtD
Cyproterone acetate—Hepatitis—Topiramate—obesity	0.000152	0.000854	CcSEcCtD
Cyproterone acetate—Dyspnoea—Bupropion—obesity	0.000151	0.000849	CcSEcCtD
Cyproterone acetate—Connective tissue disorder—Topiramate—obesity	0.000149	0.00084	CcSEcCtD
Cyproterone acetate—Dyspepsia—Bupropion—obesity	0.000149	0.000839	CcSEcCtD
Cyproterone acetate—Hypersensitivity—Orlistat—obesity	0.000148	0.000832	CcSEcCtD
Cyproterone acetate—Decreased appetite—Bupropion—obesity	0.000147	0.000828	CcSEcCtD
Cyproterone acetate—Visual impairment—Topiramate—obesity	0.000146	0.000823	CcSEcCtD
Cyproterone acetate—Gastrointestinal disorder—Bupropion—obesity	0.000146	0.000823	CcSEcCtD
Cyproterone acetate—Fatigue—Bupropion—obesity	0.000146	0.000821	CcSEcCtD
Cyproterone acetate—Constipation—Bupropion—obesity	0.000145	0.000815	CcSEcCtD
Cyproterone acetate—Asthenia—Orlistat—obesity	0.000144	0.00081	CcSEcCtD
Cyproterone acetate—Erythema multiforme—Topiramate—obesity	0.000143	0.000808	CcSEcCtD
Cyproterone acetate—Hypersensitivity—Sibutramine—obesity	0.000143	0.000805	CcSEcCtD
Cyproterone acetate—Pruritus—Orlistat—obesity	0.000142	0.000799	CcSEcCtD
Cyproterone acetate—Eye disorder—Topiramate—obesity	0.000142	0.000798	CcSEcCtD
Cyproterone acetate—Feeling abnormal—Bupropion—obesity	0.000139	0.000785	CcSEcCtD
Cyproterone acetate—Asthenia—Sibutramine—obesity	0.000139	0.000784	CcSEcCtD
Cyproterone acetate—Gastrointestinal pain—Bupropion—obesity	0.000138	0.000779	CcSEcCtD
Cyproterone acetate—Angiopathy—Topiramate—obesity	0.000138	0.000775	CcSEcCtD
Cyproterone acetate—Pruritus—Sibutramine—obesity	0.000137	0.000773	CcSEcCtD
Cyproterone acetate—Diarrhoea—Orlistat—obesity	0.000137	0.000773	CcSEcCtD
Cyproterone acetate—Immune system disorder—Topiramate—obesity	0.000137	0.000772	CcSEcCtD
Cyproterone acetate—Mediastinal disorder—Topiramate—obesity	0.000137	0.00077	CcSEcCtD
Cyproterone acetate—Chills—Topiramate—obesity	0.000136	0.000767	CcSEcCtD
Cyproterone acetate—Urticaria—Bupropion—obesity	0.000134	0.000757	CcSEcCtD
Cyproterone acetate—Alopecia—Topiramate—obesity	0.000134	0.000755	CcSEcCtD
Cyproterone acetate—Abdominal pain—Bupropion—obesity	0.000134	0.000753	CcSEcCtD
Cyproterone acetate—Body temperature increased—Bupropion—obesity	0.000134	0.000753	CcSEcCtD
Cyproterone acetate—Mental disorder—Topiramate—obesity	0.000133	0.000749	CcSEcCtD
Cyproterone acetate—Diarrhoea—Sibutramine—obesity	0.000133	0.000748	CcSEcCtD
Cyproterone acetate—Dizziness—Orlistat—obesity	0.000133	0.000747	CcSEcCtD
Cyproterone acetate—Malnutrition—Topiramate—obesity	0.000132	0.000744	CcSEcCtD
Cyproterone acetate—Tension—Topiramate—obesity	0.00013	0.00073	CcSEcCtD
Cyproterone acetate—Dizziness—Sibutramine—obesity	0.000128	0.000723	CcSEcCtD
Cyproterone acetate—Vomiting—Orlistat—obesity	0.000128	0.000718	CcSEcCtD
Cyproterone acetate—Rash—Orlistat—obesity	0.000126	0.000712	CcSEcCtD
Cyproterone acetate—Dermatitis—Orlistat—obesity	0.000126	0.000711	CcSEcCtD
Cyproterone acetate—Headache—Orlistat—obesity	0.000126	0.000707	CcSEcCtD
Cyproterone acetate—Hypersensitivity—Bupropion—obesity	0.000125	0.000702	CcSEcCtD
Cyproterone acetate—Vomiting—Sibutramine—obesity	0.000123	0.000695	CcSEcCtD
Cyproterone acetate—Ill-defined disorder—Topiramate—obesity	0.000123	0.00069	CcSEcCtD
Cyproterone acetate—Rash—Sibutramine—obesity	0.000122	0.000689	CcSEcCtD
Cyproterone acetate—Dermatitis—Sibutramine—obesity	0.000122	0.000688	CcSEcCtD
Cyproterone acetate—Anaemia—Topiramate—obesity	0.000122	0.000687	CcSEcCtD
Cyproterone acetate—Headache—Sibutramine—obesity	0.000122	0.000685	CcSEcCtD
Cyproterone acetate—Asthenia—Bupropion—obesity	0.000121	0.000684	CcSEcCtD
Cyproterone acetate—Agitation—Topiramate—obesity	0.000121	0.000683	CcSEcCtD
Cyproterone acetate—Pruritus—Bupropion—obesity	0.00012	0.000674	CcSEcCtD
Cyproterone acetate—Nausea—Orlistat—obesity	0.000119	0.000671	CcSEcCtD
Cyproterone acetate—Malaise—Topiramate—obesity	0.000119	0.000671	CcSEcCtD
Cyproterone acetate—Syncope—Topiramate—obesity	0.000118	0.000667	CcSEcCtD
Cyproterone acetate—Leukopenia—Topiramate—obesity	0.000118	0.000666	CcSEcCtD
Cyproterone acetate—Loss of consciousness—Topiramate—obesity	0.000116	0.000654	CcSEcCtD
Cyproterone acetate—Diarrhoea—Bupropion—obesity	0.000116	0.000652	CcSEcCtD
Cyproterone acetate—Nausea—Sibutramine—obesity	0.000115	0.000649	CcSEcCtD
Cyproterone acetate—Cough—Topiramate—obesity	0.000115	0.000649	CcSEcCtD
Cyproterone acetate—Dizziness—Bupropion—obesity	0.000112	0.00063	CcSEcCtD
Cyproterone acetate—Unspecified disorder of skin and subcutaneous tissue—Topiramate—obesity	0.000112	0.000629	CcSEcCtD
Cyproterone acetate—Discomfort—Topiramate—obesity	0.000111	0.000626	CcSEcCtD
Cyproterone acetate—Oedema—Topiramate—obesity	0.000108	0.000607	CcSEcCtD
Cyproterone acetate—Vomiting—Bupropion—obesity	0.000108	0.000606	CcSEcCtD
Cyproterone acetate—Rash—Bupropion—obesity	0.000107	0.000601	CcSEcCtD
Cyproterone acetate—Dermatitis—Bupropion—obesity	0.000107	0.0006	CcSEcCtD
Cyproterone acetate—Shock—Topiramate—obesity	0.000106	0.000597	CcSEcCtD
Cyproterone acetate—Headache—Bupropion—obesity	0.000106	0.000597	CcSEcCtD
Cyproterone acetate—Nervous system disorder—Topiramate—obesity	0.000106	0.000595	CcSEcCtD
Cyproterone acetate—Thrombocytopenia—Topiramate—obesity	0.000106	0.000594	CcSEcCtD
Cyproterone acetate—Tachycardia—Topiramate—obesity	0.000105	0.000592	CcSEcCtD
Cyproterone acetate—Skin disorder—Topiramate—obesity	0.000105	0.00059	CcSEcCtD
Cyproterone acetate—Hyperhidrosis—Topiramate—obesity	0.000104	0.000587	CcSEcCtD
Cyproterone acetate—Anorexia—Topiramate—obesity	0.000103	0.000579	CcSEcCtD
Cyproterone acetate—Hypotension—Topiramate—obesity	0.000101	0.000567	CcSEcCtD
Cyproterone acetate—Nausea—Bupropion—obesity	0.000101	0.000566	CcSEcCtD
Cyproterone acetate—Dyspnoea—Topiramate—obesity	9.61e-05	0.000541	CcSEcCtD
Cyproterone acetate—Dyspepsia—Topiramate—obesity	9.49e-05	0.000534	CcSEcCtD
Cyproterone acetate—Decreased appetite—Topiramate—obesity	9.37e-05	0.000528	CcSEcCtD
Cyproterone acetate—Gastrointestinal disorder—Topiramate—obesity	9.31e-05	0.000524	CcSEcCtD
Cyproterone acetate—Fatigue—Topiramate—obesity	9.3e-05	0.000523	CcSEcCtD
Cyproterone acetate—Constipation—Topiramate—obesity	9.22e-05	0.000519	CcSEcCtD
Cyproterone acetate—Feeling abnormal—Topiramate—obesity	8.89e-05	0.0005	CcSEcCtD
Cyproterone acetate—Gastrointestinal pain—Topiramate—obesity	8.82e-05	0.000496	CcSEcCtD
Cyproterone acetate—Urticaria—Topiramate—obesity	8.57e-05	0.000482	CcSEcCtD
Cyproterone acetate—Body temperature increased—Topiramate—obesity	8.52e-05	0.00048	CcSEcCtD
Cyproterone acetate—Abdominal pain—Topiramate—obesity	8.52e-05	0.00048	CcSEcCtD
Cyproterone acetate—Hypersensitivity—Topiramate—obesity	7.94e-05	0.000447	CcSEcCtD
Cyproterone acetate—Asthenia—Topiramate—obesity	7.74e-05	0.000435	CcSEcCtD
Cyproterone acetate—Pruritus—Topiramate—obesity	7.63e-05	0.000429	CcSEcCtD
Cyproterone acetate—Diarrhoea—Topiramate—obesity	7.38e-05	0.000415	CcSEcCtD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—BAD—obesity	7.21e-05	0.000853	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—IRS1—obesity	7.17e-05	0.000848	CbGpPWpGaD
Cyproterone acetate—Dizziness—Topiramate—obesity	7.13e-05	0.000401	CcSEcCtD
Cyproterone acetate—NR3C1—Adipogenesis—IRS1—obesity	7.13e-05	0.000843	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—SREBF2—obesity	7.09e-05	0.000838	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—CTNNBL1—obesity	7.08e-05	0.000837	CbGpPWpGaD
Cyproterone acetate—NR3C1—Adipogenesis—PPARG—obesity	6.96e-05	0.000823	CbGpPWpGaD
Cyproterone acetate—Vomiting—Topiramate—obesity	6.86e-05	0.000386	CcSEcCtD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—LPA—obesity	6.85e-05	0.00081	CbGpPWpGaD
Cyproterone acetate—NR3C1—Adipogenesis—INS—obesity	6.83e-05	0.000807	CbGpPWpGaD
Cyproterone acetate—Rash—Topiramate—obesity	6.8e-05	0.000383	CcSEcCtD
Cyproterone acetate—Dermatitis—Topiramate—obesity	6.79e-05	0.000382	CcSEcCtD
Cyproterone acetate—Headache—Topiramate—obesity	6.75e-05	0.00038	CcSEcCtD
Cyproterone acetate—NR3C1—Glucocorticoid receptor regulatory network—MAPK8—obesity	6.75e-05	0.000799	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—BCL2—obesity	6.74e-05	0.000797	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—GPT—obesity	6.71e-05	0.000794	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—UQCRC2—obesity	6.71e-05	0.000794	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—INPP5E—obesity	6.71e-05	0.000794	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—LPIN1—obesity	6.7e-05	0.000792	CbGpPWpGaD
Cyproterone acetate—NR3C1—Endoderm Differentiation—TGFB1—obesity	6.65e-05	0.000786	CbGpPWpGaD
Cyproterone acetate—AR—Coregulation of Androgen receptor activity—AKT1—obesity	6.64e-05	0.000786	CbGpPWpGaD
Cyproterone acetate—NR3C1—Adipogenesis—IGF1—obesity	6.6e-05	0.000781	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—APOA5—obesity	6.56e-05	0.000776	CbGpPWpGaD
Cyproterone acetate—NR3C1—FOXA2 and FOXA3 transcription factor networks—AKT1—obesity	6.55e-05	0.000774	CbGpPWpGaD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—MYC—obesity	6.51e-05	0.00077	CbGpPWpGaD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—TGFB1—obesity	6.5e-05	0.000768	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—MTOR—obesity	6.46e-05	0.000764	CbGpPWpGaD
Cyproterone acetate—Nausea—Topiramate—obesity	6.4e-05	0.000361	CcSEcCtD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—IGF1—obesity	6.4e-05	0.000757	CbGpPWpGaD
Cyproterone acetate—AR—Generic Transcription Pathway—PARP1—obesity	6.39e-05	0.000756	CbGpPWpGaD
Cyproterone acetate—NR3C1—Adipogenesis—SERPINE1—obesity	6.27e-05	0.000742	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—CLOCK—obesity	6.26e-05	0.000741	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—ME1—obesity	6.24e-05	0.000738	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—ALDH6A1—obesity	6.24e-05	0.000738	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—SUCLG2—obesity	6.24e-05	0.000738	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Biological oxidations—POMC—obesity	6.22e-05	0.000736	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—SULT2A1—obesity	6.1e-05	0.000722	CbGpPWpGaD
Cyproterone acetate—AR—Generic Transcription Pathway—ESR2—obesity	6.05e-05	0.000716	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—PPARD—obesity	5.88e-05	0.000696	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—PNPLA3—obesity	5.87e-05	0.000694	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—UCP1—obesity	5.87e-05	0.000694	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—COX7C—obesity	5.87e-05	0.000694	CbGpPWpGaD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—IL1B—obesity	5.8e-05	0.000686	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—BCL2—obesity	5.8e-05	0.000686	CbGpPWpGaD
Cyproterone acetate—NR3C1—Regulation of nuclear SMAD2/3 signaling—MYC—obesity	5.79e-05	0.000685	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—BCL2—obesity	5.58e-05	0.000661	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—CPT1A—obesity	5.58e-05	0.00066	CbGpPWpGaD
Cyproterone acetate—AR—Generic Transcription Pathway—NCOA1—obesity	5.58e-05	0.00066	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—CS—obesity	5.56e-05	0.000658	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—DGAT2—obesity	5.56e-05	0.000658	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—SUCLA2—obesity	5.56e-05	0.000658	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—CPS1—obesity	5.56e-05	0.000658	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—MTOR—obesity	5.56e-05	0.000658	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—LIPC—obesity	5.44e-05	0.000643	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—APOC3—obesity	5.4e-05	0.000639	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—NR0B2—obesity	5.36e-05	0.000634	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—NR1I3—obesity	5.36e-05	0.000634	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—MUT—obesity	5.31e-05	0.000628	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—LIPE—obesity	5.31e-05	0.000628	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—PTGS2—obesity	5.3e-05	0.000627	CbGpPWpGaD
Cyproterone acetate—AR—Regulation of nuclear SMAD2/3 signaling—AKT1—obesity	5.3e-05	0.000626	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—CETP—obesity	5.25e-05	0.000621	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—SDC1—obesity	5.19e-05	0.000614	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—AKR1C3—obesity	5.1e-05	0.000604	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—DGAT1—obesity	5.09e-05	0.000602	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—CYB5A—obesity	5.09e-05	0.000602	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—SCARB1—obesity	5.02e-05	0.000594	CbGpPWpGaD
Cyproterone acetate—AR—Androgen receptor signaling pathway—AKT1—obesity	4.91e-05	0.000581	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—NR1I2—obesity	4.9e-05	0.00058	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—ACLY—obesity	4.9e-05	0.000579	CbGpPWpGaD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—IL6—obesity	4.89e-05	0.000579	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—SREBF1—obesity	4.88e-05	0.000577	CbGpPWpGaD
Cyproterone acetate—NR3C1—Generic Transcription Pathway—PARP1—obesity	4.85e-05	0.000574	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—ENPP1—obesity	4.73e-05	0.00056	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—ALOX12—obesity	4.73e-05	0.00056	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—FASN—obesity	4.64e-05	0.000549	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—MYC—obesity	4.64e-05	0.000549	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—BCHE—obesity	4.62e-05	0.000547	CbGpPWpGaD
Cyproterone acetate—NR3C1—Generic Transcription Pathway—ESR2—obesity	4.59e-05	0.000543	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—HMGCS1—obesity	4.58e-05	0.000542	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—MAPK8—obesity	4.53e-05	0.000535	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—PPARD—obesity	4.46e-05	0.000528	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—SAT1—obesity	4.45e-05	0.000526	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—ANGPTL4—obesity	4.45e-05	0.000526	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—PFKFB3—obesity	4.45e-05	0.000526	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—PLIN1—obesity	4.45e-05	0.000526	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—PNPLA2—obesity	4.45e-05	0.000526	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—ACADM—obesity	4.45e-05	0.000526	CbGpPWpGaD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—IL1B—obesity	4.4e-05	0.000521	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—OXCT1—obesity	4.33e-05	0.000512	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—CYTB—obesity	4.33e-05	0.000512	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—ACACB—obesity	4.33e-05	0.000512	CbGpPWpGaD
Cyproterone acetate—AR—Generic Transcription Pathway—NR3C1—obesity	4.32e-05	0.000512	CbGpPWpGaD
Cyproterone acetate—NR3C1—Glucocorticoid receptor regulatory network—IL6—obesity	4.31e-05	0.00051	CbGpPWpGaD
Cyproterone acetate—NR3C1—Adipogenesis—STAT3—obesity	4.27e-05	0.000505	CbGpPWpGaD
Cyproterone acetate—NR3C1—Generic Transcription Pathway—NCOA1—obesity	4.23e-05	0.000501	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—PNLIP—obesity	4.22e-05	0.000499	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—SRD5A1—obesity	4.22e-05	0.000499	CbGpPWpGaD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—TNF—obesity	4.21e-05	0.000498	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—SDC3—obesity	4.12e-05	0.000487	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—GGT1—obesity	4.1e-05	0.000484	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—NR1I3—obesity	4.07e-05	0.000481	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—NR0B2—obesity	4.07e-05	0.000481	CbGpPWpGaD
Cyproterone acetate—NR3C1—Generic Transcription Pathway—AR—obesity	4.06e-05	0.00048	CbGpPWpGaD
Cyproterone acetate—AR—Generic Transcription Pathway—PPARA—obesity	4.05e-05	0.000479	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—NCOA1—obesity	4.03e-05	0.000477	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—STS—obesity	4.02e-05	0.000476	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—CYP26B1—obesity	4.02e-05	0.000476	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—HK2—obesity	4.02e-05	0.000476	CbGpPWpGaD
Cyproterone acetate—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—obesity	4.02e-05	0.000475	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—MYC—obesity	3.99e-05	0.000472	CbGpPWpGaD
Cyproterone acetate—NR3C1—Glucocorticoid receptor regulatory network—AKT1—obesity	3.98e-05	0.000471	CbGpPWpGaD
Cyproterone acetate—NR3C1—Adipogenesis—TGFB1—obesity	3.96e-05	0.000468	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—PPARD—obesity	3.94e-05	0.000466	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—SLC27A1—obesity	3.86e-05	0.000456	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—MYC—obesity	3.84e-05	0.000455	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—TGFB1—obesity	3.84e-05	0.000454	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—FABP4—obesity	3.78e-05	0.000447	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—GLUL—obesity	3.78e-05	0.000447	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—NR1I2—obesity	3.72e-05	0.00044	CbGpPWpGaD
Cyproterone acetate—NR3C1—Adipogenesis—TNF—obesity	3.7e-05	0.000437	CbGpPWpGaD
Cyproterone acetate—AR—Generic Transcription Pathway—ESR1—obesity	3.67e-05	0.000434	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—PPARGC1A—obesity	3.65e-05	0.000431	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—UCP3—obesity	3.59e-05	0.000424	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—HSD11B1—obesity	3.59e-05	0.000424	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—UCP2—obesity	3.59e-05	0.000424	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—ECHS1—obesity	3.59e-05	0.000424	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—TNF—obesity	3.58e-05	0.000424	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—ADH1B—obesity	3.53e-05	0.000417	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—APOB—obesity	3.48e-05	0.000411	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—PPARGC1B—obesity	3.47e-05	0.000411	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—GPAM—obesity	3.47e-05	0.000411	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—ACSL1—obesity	3.47e-05	0.000411	CbGpPWpGaD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—IL6—obesity	3.4e-05	0.000402	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—FADS1—obesity	3.37e-05	0.000399	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—HADH—obesity	3.37e-05	0.000399	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—PCK1—obesity	3.37e-05	0.000399	CbGpPWpGaD
Cyproterone acetate—AR—Generic Transcription Pathway—PPARG—obesity	3.35e-05	0.000396	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—LPL—obesity	3.32e-05	0.000393	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—ACP5—obesity	3.28e-05	0.000388	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—PIK3CA—obesity	3.26e-05	0.000386	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—GPX1—obesity	3.24e-05	0.000383	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—AKT1—obesity	3.22e-05	0.000381	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—G6PD—obesity	3.2e-05	0.000378	CbGpPWpGaD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—TNF—obesity	3.19e-05	0.000378	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—HK1—obesity	3.16e-05	0.000373	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—SREBF2—obesity	3.16e-05	0.000373	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—CD36—obesity	3.15e-05	0.000373	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—PARP1—obesity	3.08e-05	0.000364	CbGpPWpGaD
Cyproterone acetate—NR3C1—Generic Transcription Pathway—PPARA—obesity	3.07e-05	0.000364	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—LPA—obesity	3.05e-05	0.000361	CbGpPWpGaD
Cyproterone acetate—AR—Generic Transcription Pathway—SERPINE1—obesity	3.02e-05	0.000357	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—LPIN1—obesity	2.98e-05	0.000353	CbGpPWpGaD
Cyproterone acetate—NR3C1—Adipogenesis—IL6—obesity	2.98e-05	0.000353	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—PPARA—obesity	2.93e-05	0.000347	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—APOA5—obesity	2.92e-05	0.000346	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—ESR2—obesity	2.91e-05	0.000345	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—AGT—obesity	2.84e-05	0.000336	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—SLC22A1—obesity	2.79e-05	0.00033	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—CLOCK—obesity	2.79e-05	0.00033	CbGpPWpGaD
Cyproterone acetate—NR3C1—Generic Transcription Pathway—ESR1—obesity	2.79e-05	0.000329	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—APOE—obesity	2.78e-05	0.000329	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—AKT1—obesity	2.77e-05	0.000327	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—CAV1—obesity	2.76e-05	0.000326	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—APOA1—obesity	2.75e-05	0.000325	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—SULT2A1—obesity	2.72e-05	0.000321	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—GLP1R—obesity	2.72e-05	0.000321	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—NCOA1—obesity	2.69e-05	0.000318	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—DPYD—obesity	2.67e-05	0.000316	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—AKT1—obesity	2.67e-05	0.000315	CbGpPWpGaD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—IL6—obesity	2.58e-05	0.000305	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—PRKAR2B—obesity	2.57e-05	0.000304	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—DCN—obesity	2.55e-05	0.000302	CbGpPWpGaD
Cyproterone acetate—NR3C1—Generic Transcription Pathway—PPARG—obesity	2.54e-05	0.000301	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CG—obesity	2.51e-05	0.000297	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—CPT1A—obesity	2.49e-05	0.000294	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—NAMPT—obesity	2.44e-05	0.000288	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—PPARG—obesity	2.42e-05	0.000287	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—LIPC—obesity	2.42e-05	0.000286	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—GCK—obesity	2.42e-05	0.000286	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—APOC3—obesity	2.41e-05	0.000285	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—POMC—obesity	2.39e-05	0.000283	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—SIRT1—obesity	2.35e-05	0.000278	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—CETP—obesity	2.34e-05	0.000276	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—PARP1—obesity	2.34e-05	0.000276	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—SDC1—obesity	2.31e-05	0.000273	CbGpPWpGaD
Cyproterone acetate—NR3C1—Generic Transcription Pathway—SERPINE1—obesity	2.29e-05	0.000271	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—AKR1C3—obesity	2.27e-05	0.000269	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—SCARB1—obesity	2.24e-05	0.000265	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—ESR2—obesity	2.21e-05	0.000262	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CD—obesity	2.21e-05	0.000261	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—ALB—obesity	2.18e-05	0.000258	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—SREBF1—obesity	2.17e-05	0.000257	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—GOT2—obesity	2.11e-05	0.00025	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—PIK3R1—obesity	2.08e-05	0.000246	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—NR3C1—obesity	2.08e-05	0.000246	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—FASN—obesity	2.07e-05	0.000245	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—BCHE—obesity	2.06e-05	0.000244	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—NCOA1—obesity	2.04e-05	0.000241	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—PRKCD—obesity	2.04e-05	0.000241	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—CYP2E1—obesity	1.99e-05	0.000235	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—NQO1—obesity	1.96e-05	0.000232	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—AR—obesity	1.95e-05	0.000231	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—PPARA—obesity	1.95e-05	0.000231	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CB—obesity	1.92e-05	0.000228	CbGpPWpGaD
Cyproterone acetate—AR—Generic Transcription Pathway—MYC—obesity	1.91e-05	0.000226	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—obesity	1.91e-05	0.000225	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—SLC2A4—obesity	1.88e-05	0.000223	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—GCG—obesity	1.88e-05	0.000223	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—CYCS—obesity	1.86e-05	0.00022	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—GOT1—obesity	1.82e-05	0.000216	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—GGT1—obesity	1.82e-05	0.000216	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—NCOA1—obesity	1.8e-05	0.000213	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—SIRT1—obesity	1.78e-05	0.000211	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—STK11—obesity	1.77e-05	0.000209	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—ESR1—obesity	1.77e-05	0.000209	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—COMT—obesity	1.65e-05	0.000195	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—PPARGC1A—obesity	1.62e-05	0.000192	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—GNB3—obesity	1.62e-05	0.000192	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—HMOX1—obesity	1.62e-05	0.000191	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—PPARG—obesity	1.61e-05	0.000191	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—GNAS—obesity	1.58e-05	0.000187	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—APOB—obesity	1.55e-05	0.000183	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—PRKCD—obesity	1.54e-05	0.000183	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—PPARA—obesity	1.48e-05	0.000175	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—LPL—obesity	1.48e-05	0.000175	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—SERPINE1—obesity	1.45e-05	0.000172	CbGpPWpGaD
Cyproterone acetate—NR3C1—Generic Transcription Pathway—MYC—obesity	1.45e-05	0.000171	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—GPX1—obesity	1.44e-05	0.000171	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—CD36—obesity	1.4e-05	0.000166	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—ESR1—obesity	1.34e-05	0.000159	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—MTHFR—obesity	1.33e-05	0.000157	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—PPARA—obesity	1.31e-05	0.000154	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—AGT—obesity	1.26e-05	0.00015	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—APOE—obesity	1.24e-05	0.000147	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—CAV1—obesity	1.23e-05	0.000145	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—APOA1—obesity	1.22e-05	0.000145	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—PPARG—obesity	1.22e-05	0.000145	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CA—obesity	1.17e-05	0.000139	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—PIK3CG—obesity	1.12e-05	0.000132	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—SERPINE1—obesity	1.1e-05	0.00013	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—PPARG—obesity	1.08e-05	0.000128	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—POMC—obesity	1.06e-05	0.000126	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—INS—obesity	1.06e-05	0.000125	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—PIK3CD—obesity	9.83e-06	0.000116	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—ALB—obesity	9.7e-06	0.000115	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—NOS3—obesity	9.28e-06	0.00011	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—PIK3R1—obesity	9.28e-06	0.00011	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—MYC—obesity	9.19e-06	0.000109	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—PIK3CB—obesity	8.57e-06	0.000101	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—PTGS2—obesity	8.49e-06	0.0001	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—MYC—obesity	6.98e-06	8.25e-05	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—AKT1—obesity	6.38e-06	7.54e-05	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—PIK3CA—obesity	5.22e-06	6.18e-05	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—AKT1—obesity	4.84e-06	5.72e-05	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—AKT1—obesity	4.27e-06	5.05e-05	CbGpPWpGaD
